(Q34805783)

4 August 2017

1 reference

title

A reevaluation of integrins as regulators of angiogenesis (English)

1 reference

4 August 2017

1 reference

Richard O Hynes

1

1 reference

PubMed ID

12205444

4 August 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

4 August 2017

1 reference

4 August 2017

8

1 reference

4 August 2017

918-921

1 reference

4 August 2017

9

1 reference

https://scigraph.springernature.com/pub.10.1038/nm0902-918

4 August 2017

0 references

cites work

Integrins: versatility, modulation, and signaling in cell adhesion

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Function and interactions of integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Integrins in vascular development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Adhesion events in angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Requirement of vascular integrin alpha v beta 3 for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Consequences of lack of beta 1 integrin gene expression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Deletion of beta 1 integrins in mice results in inner cell mass failure and peri-implantation lethality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Beta 1 integrin is essential for teratoma growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Normal development, wound healing, and adenovirus susceptibility in beta5-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Inactivation of the integrin beta 6 subunit gene reveals a role of epithelial integrins in regulating inflammation in the lung and skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Defective associations between blood vessels and brain parenchyma lead to cerebral hemorrhage in mice lacking alphav integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Sensing the environment: a historical perspective on integrin signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Trans-dominant inhibition of integrin function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

The functions of thrombospondin-1 and-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Thrombospondins: multifunctional regulators of cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Interaction of endostatin with integrins implicated in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Tumstatin, an endothelial cell-specific inhibitor of protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

A molecular mechanism of integrin crosstalk: alphavbeta3 suppression of calcium/calmodulin-dependent protein kinase II regulates alpha5beta1 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

The alphavbeta3 integrin regulates alpha5beta1-mediated cell migration toward fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

The inhibition of vascular smooth muscle cell migration by peptide and antibody antagonists of the alphavbeta3 integrin complex is reversed by activated calcium/calmodulin- dependent protein kinase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Regulation of integrin alpha vbeta 3-mediated endothelial cell migration and angiogenesis by integrin alpha5beta1 and protein kinase A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Networks and crosstalk: integrin signalling spreads.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

The extracellular matrix as a cell survival factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

RGD peptides induce apoptosis by direct caspase-3 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Intrinsic activating properties of GP IIb/IIIa blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

Definition of Two Angiogenic Pathways by Distinct alpha(v) Integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

7 January 2021

Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

7 January 2021

Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

7 January 2021

Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

7 January 2021

Interaction of endostatin with integrins implicated in angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

7 January 2021

Glycoprotein IIb/IIIa antagonists induce apoptosis in rat cardiomyocytes by caspase-3 activation

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

7 January 2021

Integrin-mediated death: an explanation of the integrin-knockout phenotype?

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-918

7 January 2021

Identifiers

DOI

10.1038/NM0902-918

1 reference

release_ebbg45cwrzdorku4ddz5rinkhq

4 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ebbg45cwrzdorku4ddz5rinkhq

24 November 2022

mapped directly with Wikidata item

PubMed ID

12205444

1 reference

PubMed ID

12205444